medigraphic.com
Órgano Oficial del Hospital Angeles Health System

2018, Number 1

<< Back Next >>

Acta Med 2018; 16 (1)

Generalities of alcohol use disorder

Navarrete HBR, Secín DR

Language: Spanish
References: 32
Page: 47-53
PDF size: 129.34 Kb.


ABSTRACT

Drug addiction is one of the most important health problems worldwide today. Only recently, addiction was recognized as a medical problem, so that awareness of disease in the general population is low. For example, in US there is evidence that only 20% of the population of addicts is receiving treatment. The problem of addiction treatment is that it requires an approach at all levels of scientific knowledge to understand the dynamics of this process. In the addictive spectrum, alcohol influences both the incidence and the course of many medical conditions and about 6% of all deaths worldwide in 2012, may be attributable to the use of it. The number of hospital admissions related to alcohol consumption has increased, for example in the UK, the number of patients admitted double between 2001 and 2012. Different studies show that over 20% of patients attending primary care points and emergency units have alcohol use disorder and/or dependence, however are not identified and therefore channeled to specialized attention. Therefore, it is important in primary care areas to have a greater knowledge on this problem identification and treatment.


REFERENCES

  1. Moore RD, Bone LR, Geller G, Mamon JA, Stokes EJ, Levine DM. Prevalence, detection and treatment of alcoholism in hospitalized patients. JAMA. 1989; 261 (3): 403-407.

  2. Funk M, Wutzke S, Kaner E, Anderson P, Pas L, McCormick R et al. A multicountry controlled trial of strategies to promote dissemination and implementation of brief alcohol intervention in primary health care: findings of a World Health Organization collaborative study. J Stud Alcohol. 2005; 66 (3): 379-388.

  3. World Health Organization. Global status report on alcohol and health 2014. WHO, 2014.

  4. Health and Social Care Information Centre. Statistics on alcohol: England, 2013. HSCIC, 2013.

  5. Bobes-García J, Casas-Brugué M, Gutiérrez-Fraile M. Manual de evaluación y tratamiento de drogodependencias. Psiquiatría Editores SL 2003; 232-257.

  6. Palomo T, Beninger JR, Jiménez Arriero MA, Huertas E, Archer T. Neuroimagen en psiquiatría. Ed. CYM. Fundación Cerebro y Mente. Madrid 2002: Síntesis.

  7. Cunningham CL. Drug conditioning and drug-seeking behavior. Ed. Learning and behavior therapy. Needham Heights 1998: Allyn and Bacon.

  8. Bickel WK, DeGrandpre RJ, Higgins ST. The behavioral economics of concurrence drug reinforcements: a review and reanalysis of drug self-administration research. Psychopharmacol. 1995; 118: 250-259.

  9. Nestler EJ, Hyman SE, Malenka RC. Molecular neuropharmacology: a foundation for clinical neuroscience. New York, McGraw-Hill, 2001, p. 539.

  10. Koob GF, Roberts AJ, Schulteis G, Parsons LH, Heyser CJ, Hyytia P et al. Neurocircuitry targets in ethanol reward and dependence. Alcohol Clin Exp Res. 1998; 22 (1): 3-9.

  11. Volkow ND, Ma Y, Zhu W, Fowler JS, Li J, Rao M et al. Moderate doses of alchol disrupt the functional organization of the human brain. Psychiatry Res. 2008; 162 (3): 205-213.

  12. Peterson JB, Rothfleisch J, Zelazo PD, Pihl RO. Acute alcohol intoxication and cognitive functioning. J Stud Alcohol. 1990; 51 (2): 114-122.

  13. Grace AA. The tonic/phasic model of dopamine system regulation and its implications for understanding alcohol and psychostimulant craving. Addiction. 2000; 95 (Suppl 2): S119-128.

  14. Koob GF. Animal models of craving for ethanol. Addiction. 2000; 95 (Suppl 2): S73-81.

  15. Ruiz CAE, Méndez DM, Prieto GB, Romano A, Caynas S, Prospéro GO. El Cerebro, las drogas y los genes. Salud Ment. 2010; 33 (6): 535-542.

  16. Nutt D. Alcohol and the brain: pharmacological insights for psychiatrists. Br J Psychiatry. 1999; 175: 114-119.

  17. San Molina L. Consenso de la SEP sobre patología dual. Barcelona: Ars. Médica Psiquiatría editores; 2004.

  18. Medina-Mora ME, Borges G, Lara MC, Benjet C, Blanco JJ, Fleiz BC y cols. Prevalencia de trastornos mentales y uso de servicios: Resultados de la Encuesta Nacional de Epidemiología Psiquiátrica en México. Salud Mental 2003; 26 (4): 1-16.

  19. Valdespino J, Olaiz G, López-Barajas MP, Mendoza L, Palma O, Velázquez O, Tapia R, Sepúlveda J. Encuesta Nacional de Salud 2000. Tomo I. Vivienda, población y utilización de servicios de salud. Cuernavaca, Morelos, México. Instituto Nacional de Salud Pública, 2003.

  20. Olaiz-Fernández G, Rivera-Dommarco J, Shamah-Levy T, Rojas R, Villapando-Hernández S, Hernández-Ávila M y cols. Encuesta Nacional de Salud y Nutrición 2006. Cuernavaca, México: Instituto Nacional de Salud Pública, 2006.

  21. Gutiérrez JP, Rivera-Dommarco J, Shamah-Levy T, Villalpando-Hernández S, Franco A, Cuevas-Nasu L y cols. Encuesta Nacional de Salud y Nutrición 2012. Resultados Nacionales. Cuernavaca, México: Instituto Nacional de Salud Pública (MX), 2012.

  22. Saunders JB, Aasland OG, Babor TF, De la Fuente JR, Grant M. Development of the alcohol use disorders identification test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumpion-II. Addiction. 1993; 88 (6): 791-804.

  23. American Psychiatric Association. DSM-IV-TR. Manual diagnóstico y estadístico de los trastornos mentales, 4ª ed. Texto revisado. Barcelona, Masson 2002.

  24. National Institute on Drug Abuse. Enfoques de tratamiento para la drogadicción. NIDA, 2015.

  25. American Psychiatric Association. DSM-5. Manual diagnóstico y estadístico de los trastornos mentales, 5ª ed. Arlington, VA, Asociación Americana de Psiquiatría, 2014, pp. 481-503.

  26. Jackson R, Johnson M, Campbell F, Messina J, Guillaume L, Meier P et al. Screening and brief intervention for prevention and early identification of alcohol ure dirsorder in adults and young people. School of Health and Related Reserch (ScHARR) Public Health Collaborating Center, 2010.

  27. Kaner E, Bland M, Cassidy P, Coulton S, Dale V, Deluca P et al. Effectiveness of screening and brief alcohol intervention in primary care (SIPS trial): pragmatic cluster randomized controlled trial. BMJ. 2013; 346: e8501.

  28. Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG. AUDIT: the alcohol use disorder identification test. Guidelines for use in primary health care. World Health Organization, 2001, 1-40.

  29. Allen JP, Litten RZ, Fertig JB, Babor TA. A review of research on the alcohol use disorders identification Test (AUDIT). Alcoholism Clin Exp Res. 1997; 21 (4): 613-619.

  30. Rumpf HJ, Bohlmann J, Hill A et al. Physicians’ low detection rates of alcohol dependence or abuse: a matter of methodological shortcomings? Gen Hosp Psychiatry. 2001; 23 (3): 133-137.

  31. Medina-Mora y cols. Encuesta Nacional de Adicciones. Instituto Nacional de Salud Pública. México, 2008.

  32. Brubacher JR, Mabie A, Ngo M, Abu-Laban RB, Buchanan J, Shenton T et al. Substance-related problems in patients visiting an urban Canadian emergency department. CJEM. 2008; 10 (3): 198-204.1.




2020     |     www.medigraphic.com